MADHAVBAUG Stock Overview
Distributes ayurvedic medicines and products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Vaidya Sane Ayurved Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹145.00 |
| 52 Week High | ₹251.00 |
| 52 Week Low | ₹107.00 |
| Beta | 0.065 |
| 1 Month Change | 3.57% |
| 3 Month Change | -0.14% |
| 1 Year Change | -35.71% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 37.57% |
Recent News & Updates
Recent updates
Investors Aren't Entirely Convinced By Vaidya Sane Ayurved Laboratories Limited's (NSE:MADHAVBAUG) Revenues
Nov 08
Should You Be Adding Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) To Your Watchlist Today?
Aug 25Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable
Jun 11Shareholder Returns
| MADHAVBAUG | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -1.0% | 0.4% | -0.9% |
| 1Y | -35.7% | 43.5% | 22.5% |
Return vs Industry: MADHAVBAUG underperformed the Indian Healthcare industry which returned 43.5% over the past year.
Return vs Market: MADHAVBAUG underperformed the Indian Market which returned 22.5% over the past year.
Price Volatility
| MADHAVBAUG volatility | |
|---|---|
| MADHAVBAUG Average Weekly Movement | 7.0% |
| Healthcare Industry Average Movement | 5.8% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: MADHAVBAUG has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: MADHAVBAUG's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 636 | Shripad Upasani | madhavbaug.org |
Vaidya Sane Ayurved Laboratories Limited, together with its subsidiaries, distributes ayurvedic medicines and products in India. It operates through Sale of Product and Hospital Activity segments. The company sells medicines for arthritis and joint pains, cholesterol, diabetes, digestive, acidity, gastric, dyslipidemia, fever, cough, cold, general tonic, heart disease, hypertension/high blood pressure, liver, low glycemic index atta, obesity/weight management, piles and renal, skin, and wounds; and diet boxes, glow gorgeous cosmetics, health supplements, healthy breakfast, laxatives, low fat oil, immunity boosters, nutri snacks, and stevia products through its clinics and online shop.
Vaidya Sane Ayurved Laboratories Limited Fundamentals Summary
| MADHAVBAUG fundamental statistics | |
|---|---|
| Market cap | ₹1.52b |
| Earnings (TTM) | ₹40.52m |
| Revenue (TTM) | ₹900.32m |
37.6x
P/E Ratio1.7x
P/S RatioIs MADHAVBAUG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MADHAVBAUG income statement (TTM) | |
|---|---|
| Revenue | ₹900.32m |
| Cost of Revenue | ₹222.36m |
| Gross Profit | ₹677.96m |
| Other Expenses | ₹637.44m |
| Earnings | ₹40.52m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.85 |
| Gross Margin | 75.30% |
| Net Profit Margin | 4.50% |
| Debt/Equity Ratio | 1.9% |
How did MADHAVBAUG perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 00:56 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vaidya Sane Ayurved Laboratories Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|